Literature DB >> 22886094

Autoimmune retinopathy associated with colonic adenoma.

Wataru Saito, Satoru Kase, Hiroshi Ohguro, Susumu Ishida.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886094     DOI: 10.1007/s00417-012-2131-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Slowly progressive cancer-associated retinopathy.

Authors:  Wataru Saito; Satoru Kase; Hiroshi Ohguro; Naoki Furudate; Shigeaki Ohno
Journal:  Arch Ophthalmol       Date:  2007-10

2.  Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.

Authors:  J R Heckenlively; A A Fawzi; J Oversier; B L Jordan; N Aptsiauri
Journal:  Arch Ophthalmol       Date:  2000-11

3.  Invasive thymoma with paraneoplastic retinopathy.

Authors:  Gen Yamada; Hiroshi Ohguro; Katsuyuki Aketa; Takayuki Itoh; Noriharu Shijubo; Hiroki Takahashi; Osamutaro Fujiwara; Masaaki Satoh; Kenji Ohtsuka; Shosaku Abe
Journal:  Hum Pathol       Date:  2003-07       Impact factor: 3.466

Review 4.  Paraneoplastic retinopathies and optic neuropathies.

Authors:  Jane W Chan
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

Review 5.  Autoimmune retinopathy: a review and summary.

Authors:  John R Heckenlively; Henry A Ferreyra
Journal:  Semin Immunopathol       Date:  2008-04-12       Impact factor: 9.623

  5 in total
  2 in total

1.  Recoverin-associated retinopathy secondary to Warthin tumor of parotid gland.

Authors:  Shigeki Machida; Hiroshi Ohguro; Kazunori Ishida; Masamichi Suzuki; Kazuaki Kawagishi
Journal:  Doc Ophthalmol       Date:  2014-08-23       Impact factor: 2.379

2.  A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsin response mediator protein-5, recoverin, and α-enolase.

Authors:  Michiyuki Saito; Wataru Saito; Atsuhiro Kanda; Hiroshi Ohguro; Susumu Ishida
Journal:  BMC Ophthalmol       Date:  2014-01-16       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.